72F fusion protein
From Wikipedia, the free encyclopedia
72F fusion protein is a candidate tuberculosis vaccine created by SSI. The 72F fusion protein is composed of the Rv0125 and Rv1196 proteins derived from Mycobacterium tuberculosis. Phase I clinical trials were completed in 2005 and Phase II trials are awaited.
[edit] See also
[edit] References
- Kaufmann SHE, McMichael AJ (2005). "Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis". Nature Med 11 (4 suppl): S33–S44. DOI:10.1038/nm1221. PMID 15812488. Retrieved on 2006-04-30.
 |
This immunology article is a stub. You can help Wikipedia by expanding it. |
